Both in Pharmaceuticals
Parabilis Medicines vs Enliven Therapeutics
Over the past year PBLS returned −23.2% and ELVN returned −18.5%; their daily moves had a correlation of 0.52.
PBLS −23.2% ELVN −18.5%Growth of $1, one year, split-adjusted
| Metric | PBLS | ELVN |
|---|---|---|
| Price | $28.32 | $44.25 |
| Market cap | $3.50B | $3.24B |
| Today | −1.32% | −1.84% |
| 1 month | −7.0% | −4.2% |
| 6 months | — | +6.1% |
| Year to date | — | +187.3% |
| 1 year | — | +95.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −45239.9% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $1.11B | $895.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 40.0% |
| Short % of float | 9.1% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).